ACADIA PHARMACEUTICALS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $199.8M | $102.1M |
| FY2016 | — | $518.4M | $163.6M |
| FY2017 | — | $335.3M | $69.4M |
| FY2018 | — | $479.1M | $134.8M |
| FY2019 | — | $699.1M | $189.7M |
| FY2020 | — | $627.0M | $326.0M |
| FY2021 | — | $540.9M | $147.4M |
| FY2022 | — | $400.4M | $114.8M |
| FY2023 | — | $431.8M | $188.7M |
| FY2024 | — | $732.8M | $319.6M |